Bryan Garnier - Ahold Delhaize (AD) Ahold Delhaize: surfing on USD while sticking to good execution on profitability

Report

Bryan Garnier

Clement Genelot

Ahold Delhaize: surfing on USD while sticking to good execution on profitability

Understanding the Q4 US EBIT miss and looking ahead to 2025 is reassuring in terms of Ahold Delhaize's ability to continue to turn around its underperforming US banners, optimise Europe and integrate Profi while sustaining a strong EBIT margin. PT lifted to EUR37 mostly thanks to the USD surge sinc

14/02/2025 1 EN

Underlying

Ahold Delhaize

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Clement Genelot

Other Reports on these Companies

Sabadell

AHOLD DELHAIZE: RDOS. 4T’24 (ANÁLISIS BANCO SABADELL)

Rdos. 4T'24 vs 4T'23: Ventas: 23.276 M euros (+1,1% vs +0,4% BS(e) y +0,8% consenso); EBIT: 958,0 M euros (-3,8% vs -6,9% BS(e) y -5,5% consenso); BDI: 380,0 M euros (-15,7% vs +44,1% BS(e) y +48,6% consenso). Rdos. 2024 vs 2023: Ventas: 89.356 M euros (+0,8% vs +0,6% BS(e) y +0,7% consenso); EBIT: 3.608 M euros (+0,1% vs -0,8% BS(e) y -0,4% consenso); BDI: 1.764 M euros (-5,9% vs +8,5% BS(e) y +9,6% consenso).

EUR 100.00

February 12, 2025 February 12, 2025 1 ES

Bryan Garnier

On the shelves now: Consumer Weekly #53

In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. Happy reading!

January 13, 2025 January 13, 2025 1 EN

Valneva: EU approves label extension to adolescents for Ixchiq

Valneva announced that the EC has granted marketing authorization in EU for Ixchiq in individuals aged >12y.o, marking an important step in line with the label extension strategy for the asset as well as allowing Valneva to close the gap on the label presented by Bavarian's Vimkunya (approved in

20h / 10m 20h / 10m 1 EN

Maria Vara

Maria Vara

Median technologies: Full RELIVE results cement eyonis case, to launch in Q4

Yesterday post-market, Median Technologies released the full results from its pivotal RELIVE study, confirming that eyonis LCS, its AI-powered SaMD for lung cancer screening, met all secondary endpoints in addition to the previously announced primary endpoint (p = 0.027). The final data reinforces

April 1, 2025 April 1, 2025 1 EN

Maria Vara

Maria Vara

ONWARD: FY24 Update – Commercial inflection begins, near-term milestones ahead

This morning, ONWARD shared FY 2024 business update highlighting a highly comprehensive list of achievements across clinical development, IP and corporate actions, while posting the first commercial sales of ARC EX following its de Novo FDA approval on 20th December. As communicated previously, two

April 1, 2025 April 1, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Ahold Delhaize: surfing on USD while sticking to good execution on profitability

AHOLD DELHAIZE: RDOS. 4T’24 (ANÁLISIS BANCO SABADELL)

On the shelves now: Consumer Weekly #53

Valneva: EU approves label extension to adolescents for Ixchiq

Median technologies: Full RELIVE results cement eyonis case, to launch in Q4

ONWARD: FY24 Update – Commercial inflection begins, near-term milestones ahead

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe